Ms. Pietrofeso joined Oncternal in September 2021 as Senior Director Clinical Operations and was promoted to VP Clinical Development Operations in September 2022. Ms. Pietrofeso has over 20 years of extensive global expertise in biopharmaceutical and medical device industries. She has a broad range of therapeutic experience in oncology, ulcerative colitis, cardiovascular medical devices, acute pain, and infectious diseases. Before joining Oncternal, Ms. Pietrofeso held positions of increasing responsibility at Pfizer, Valeant, Metabasis, Cadence Pharmaceuticals, Lithera, W.L Gore & Associates, and Gossamer Bio. Her career highlights include contributions to the successful NDA for Sutent® at Pfizer; the NDA submission for Ofirmev® at Cadence Pharmaceuticals; and the PMA approval of GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) at W.L Gore & Associates. Prior to joining industry Ms. Pietrofeso worked as a Research Nurse Manager at the Royal Free Hospital (London UK) and as a Registered Nurse in South Africa and UK. Ms. Pietrofeso holds a Bachelor of Social Science ( Nursing) from University of Natal ( Durban South Africa).
